Amedisys Stock Insider Trading

Healthcare > Medical - Care Facilities

Buy AMED

*Your capital is at risk

$100.99

+0 (+0%)

At Close: Nov 13, 2025

Amedisys Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -40.81. In total, the insiders bought 208.21K and sold 14.79M AMED shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-40.81
● Buy	208.21K shares
● Sell	14.79M shares
14% Buy Activity Weak Negative Correlation
Buy Signal Low Confidence Aug 14, 2025 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -40.81. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Aug 14, 2025 Buy	Common Stock M-Exempt	Ginn Scott G EVP, CFO & COO	C-Suite Officer	10 399 Value: $1.05M
Aug 14, 2025 Sell	Common Stock D-Return	Ginn Scott G EVP, CFO & COO	C-Suite Officer	2 714 Value: $0
Aug 14, 2025 Buy	Restricted Stock Unit (Performance-Based Vesting) M-Exempt	Ginn Scott G EVP, CFO & COO	C-Suite Officer	10 399 Value: $1.05M
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Ginn Scott G EVP, CFO & COO	C-Suite Officer	424 Value: $24.9K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Ginn Scott G EVP, CFO & COO	C-Suite Officer	6 995 Value: $344.5K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Ginn Scott G EVP, CFO & COO	C-Suite Officer	4 294 Value: $545.8K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Ginn Scott G EVP, CFO & COO	C-Suite Officer	2 997 Value: $595.8K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Ginn Scott G EVP, CFO & COO	C-Suite Officer	3 200 Value: $944.6K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Ginn Scott G EVP, CFO & COO	C-Suite Officer	6 119 Value: $876.5K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Ginn Scott G EVP, CFO & COO	C-Suite Officer	8 627 Value: $791.7K
Aug 14, 2025 Sell	Common Stock D-Return	Bohnert Denise M. Chief Compliance Officer	Officer	9 283 Value: $9
Aug 14, 2025 Buy	Common Stock M-Exempt	Bohnert Denise M. Chief Compliance Officer	Officer	3 468 Value: $350.2K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Bohnert Denise M. Chief Compliance Officer	Officer	263 Value: $12.2K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Bohnert Denise M. Chief Compliance Officer	Officer	682 Value: $65.3K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Bohnert Denise M. Chief Compliance Officer	Officer	1 907 Value: $223.9K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Bohnert Denise M. Chief Compliance Officer	Officer	1 199 Value: $238.4K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Bohnert Denise M. Chief Compliance Officer	Officer	1 067 Value: $315.0K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Bohnert Denise M. Chief Compliance Officer	Officer	2 040 Value: $292.2K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Bohnert Denise M. Chief Compliance Officer	Officer	2 876 Value: $263.9K
Aug 14, 2025 Sell	Common Stock D-Return	Bohnert Denise M. Chief Compliance Officer	Officer	214 Value: $0
Aug 14, 2025 Buy	Restricted Stock Unit (Performance-Based Vesting) M-Exempt	Bohnert Denise M. Chief Compliance Officer	Officer	3 468 Value: $350.2K
Aug 14, 2025 Sell	Common Stock D-Return	Samuels Ivanetta Davis Director	Director	7 600 Value: $8
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Ashworth Richard M President And CEO	CEO / President	22 474 Value: $1.79M
Aug 14, 2025 Buy	Restricted Stock Unit (Performance-Based Vesting) M-Exempt	Ashworth Richard M President And CEO	CEO / President	39 850 Value: $4.02M
Aug 14, 2025 Sell	Common Stock D-Return	Ashworth Richard M President And CEO	CEO / President	39 850 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AMEDISYS INC

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitatio...

Read Full Profile Here